瘤突变负担高的乳腺癌的基因组特征
Theodore Vougiouklakis1, Chad Vanderbilt1, Satshil Rana1
1Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
NPJ precision oncology
|August 7, 2025
概括
乳腺癌中的高瘤突变负担 (TMB) 通常与APOBEC签名和特定基因变异有关. 了解这些基因组特征可能会改善对免疫检查点阻塞疗法的反应.
科学领域:
- 基因组学就是基因组学.
- 癌症研究 癌症研究
- 免疫学 免疫学 免疫学
背景情况:
- 瘤突变负担 (TMB) 是免疫检查点 (IC) 阻塞反应的潜在生物标志物.
- 它在乳腺癌 (BC) 中的作用需要进一步阐明.
- 描述高TMB的BCs可以揭示关键的基因组预测因素.
研究的目的:
- 综合分析高TMB乳腺癌 (TMB ≥10突变/Mb) 的基因组景观.
- 确定乳腺癌中IC阻塞反应的潜在预测因子.
- 了解TMB高BC的突变特征和相关的遗传变化.
主要方法:
- 527个高TMB乳腺癌样本的基因组表征.
- 对突变特征的分析,重点是阿波利波蛋白B mRNA编辑酶催化聚 (APOBEC).
- 丰富基因变异的鉴定 (KMT2C,ARID1A,PTEN,NF1,RB1) 以及它们与突变发生和免疫细胞排除的关联.
主要成果:
- 在高TMB的BC.中,APOBEC是主要的突变特征 (64.7%).
- 与APOBEC突变发生相关的KMT2C,ARID1A,PTEN,NF1和RB1变化的丰富.
- 功能丧失的ARID1A和PTEN变化与免疫细胞排除有关.
- ESR1 p.E380Q是普遍存在的ESR1突变,支持APOBEC活动.
- 与非高TMB的BC相比,DNA损伤反应和修复基因突变的频率增加.
结论:
- 高TMB的乳腺癌的特征是APOBEC突变和特定的遗传改变.
- 这些基因组特征,包括ARID1A和PTEN的功能丧失突变,可能会影响免疫反应.
- 这些发现支持进一步研究针对DNA损伤修复和免疫检查点的组合疗法,以提高疗效.
相关概念视频
Mutagenicity and Carcinogenicity
1.4K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.4K
Cancer-Critical Genes I: Proto-oncogenes
9.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K
Cancer-Critical Genes II: Tumor Suppressor Genes
8.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.0K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Cancers Originate from Somatic Mutations in a Single Cell
12.8K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.8K


